NCT02184065View on ClinicalTrials.gov

Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases

CompletedOBSERVATIONAL
Enrollment

22,639

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2007

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Meloxicam

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184065 - Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases | Biotech Hunter | Biotech Hunter